Twice-yearly subcutaneous injections significantly reduced exacerbations in hard-to-treat patients. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-add-depemokimab-severe-asthma-2025a1000zt4?src=rss Author : Publish date : 2025-12-19 11:29:00 Copyright for syndicated content belongs to the...
Read more












